What is the appropriate treatment for conjunctivitis in an 18‑month‑old child?

Treatment of Conjunctivitis in an 18-Month-Old Child

For an 18-month-old with conjunctivitis, initiate a 5-7 day course of broad-spectrum topical antibiotic drops (moxifloxacin or azithromycin) for presumed bacterial infection, while recognizing that viral conjunctivitis is self-limited and requires only supportive care. 1

Initial Clinical Assessment

Determine the likely etiology based on specific clinical features:

Bacterial Conjunctivitis (Most Common in This Age Group)

• Mucopurulent or purulent discharge with eyelids matted shut upon awakening 2
• Unilateral or bilateral bulbar conjunctival injection 1
• Foreign body sensation 3
• At 18 months, the most common causative organisms are Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis 3

Viral Conjunctivitis

• Watery discharge (not purulent) 2
• Often bilateral with follicular reaction 4
• May have associated upper respiratory symptoms 2
• Self-limited, resolving within 2-3 weeks 1

Treatment Algorithm

For Mild-to-Moderate Bacterial Conjunctivitis

Topical antibiotic therapy is recommended to shorten symptom duration, reduce transmissibility, and enable earlier return to daycare, despite the self-limited nature of most cases. 1

First-Line Options:

• Azithromycin 1.5% eye drops: twice daily for 3 days 1, 5

  • Superior to tobramycin in achieving clinical cure by day 3 (47.1% vs 28.7%) in pediatric patients 5
  • More convenient dosing regimen than older agents 5

• Moxifloxacin 0.5% eye drops: four times daily for 7 days 1, 6

  • Equivalent efficacy to polymyxin B-trimethoprim with 95% clinical cure rate by day 7-10 6

• Polymyxin B-trimethoprim: four times daily for 7 days 6

  • Cost-effective alternative with 96% clinical cure rate 6
  • No statistically significant difference from fluoroquinolones 6

Topical antibiotics achieve greatest benefit between days 2-5 of therapy, with earlier clinical and microbiological remission than placebo. 1

For Severe Bacterial Conjunctivitis

Defined by copious purulent discharge, ocular pain, and marked inflammation: 1

• Obtain conjunctival cultures and Gram stain before initiating therapy 1
• Consider empiric MRSA coverage in severe cases due to rising prevalence 1
• Reassess in 3-4 days if no improvement 1

For Suspected Gonococcal Conjunctivitis

Red flags: marked eyelid edema, significant purulent discharge, preauricular lymphadenopathy, or any corneal involvement 4

• Systemic antibiotic therapy is mandatory for eradication 1
• Saline lavage for comfort 1
• Consider sexual abuse in any child with gonococcal infection 4, 1
• Daily ophthalmology follow-up with slit-lamp examination until complete resolution 1
• Potential sequelae include corneal perforation, septicemia, arthritis, and meningitis 4

For Suspected Chlamydial Conjunctivitis

Clinical features: eyelid edema, bulbar injection, discharge may be purulent, mucopurulent, or blood-stained; no follicles in infants 4

• Systemic antimicrobial therapy is required because >50% have concurrent nasopharyngeal, genital, or pulmonary infection 1
• No evidence supports adding topical antibiotics to systemic treatment 1
• Treatment failure occurs in up to 19% of cases; re-evaluation after therapy is essential 1
• Consider sexual abuse in children with chlamydial conjunctivitis 1

For Viral Conjunctivitis

• Supportive care only: artificial tears, cold compresses, antihistamine eye drops for symptom relief 2
• Strict hand hygiene to prevent transmission 2
• Self-limited, typically resolving within 2-3 weeks 1
• Return for evaluation if symptoms persist beyond 2-3 weeks 1

Immediate Ophthalmology Referral Required For:

• Visual loss or moderate-to-severe ocular pain 1
• Severe purulent discharge 1
• Corneal involvement (infiltrate, ulcer, or opacity) 4, 1
• Lack of response to therapy after 3-4 days 1
• Vesicular rash on eyelids or nose (suggests HSV) 2
• Immunocompromised state 1, 2

Common Pitfalls to Avoid:

• Do not withhold antibiotics in bacterial conjunctivitis: While most cases are self-limited 7, topical antibiotics reduce discomfort, prevent person-to-person transmission, and enable earlier return to daycare 1, 3
• Do not miss gonococcal or chlamydial infection: These require systemic therapy and have serious sequelae if untreated 4, 1
• Do not use topical corticosteroids without ophthalmology consultation, especially if HSV is possible, as steroids exacerbate HSV epithelial infection 1
• Do not assume improvement means cure in chlamydial cases: Re-evaluation is essential due to 19% treatment failure rate 1